MUC1 and glioblastoma: Notably, many other CARs targeting other antigens on GBM including CAR T cells for GBM therapy are ephrin type-A receptor 2 (EphA2) (NCT02575261), and mucin 1 (MUC1) (NCT02839954, NCT02617134) are currently being developed.